CSPC Pharmaceutical Group Limited. - ADR

CSPC Pharmaceutical Group Limited. - ADR

CSPCY

Get informed when a big investor buys or sells

+ Follow
Market Cap$10.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
CSPC Pharmaceutical Group Limited. - ADRCSPC Pharmaceutical Group Limited. - ADR18.93.31%13%0.3-
$2.00

Current Fair Value

44.9% downside

Overvalued by 44.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$10.43 Billion
Enterprise Value$5.10 Billion
Dividend Yield$0.07 (3.31%)
Earnings per Share$1.32
Beta0.73
Outstanding Shares2,881,316,000

Return

Return on Equity13.00%ROE
Return on Assets9.23%
Return on Invested Capital18.92%

Valuation & Multiples

P/E Ratio18.89P/E Ratio
PEG-232.6PEG
Price to Sales0.28Price to Sales
Price to Book Ratio0.28Price to Book Ratio
Enterprise Value to Revenue0.14
Enterprise Value to EBIT0.66
Enterprise Value to Net Income1
Total Debt to Enterprise0.28
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 27, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
$7.58 B
Average shareholder expectation

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

ESG Score

No data

About CSPC Pharmaceutical Group Limited.

Relevant Senate Committees

Finance

This powerful committee controls taxation, trade, and entitlement spending (like Medicare). Tax policy directly impacts corporate profitability, Medicare pricing significantly affects drug revenue, and trade policy impacts global supply chains for an international pharmaceutical company.

Health, Education, Labor, and Pensions

This committee directly regulates the Food and Drug Administration (FDA), which is the primary regulatory body for pharmaceutical drug approval, manufacturing standards, and post-market surveillance. It also influences NIH funding.

Judiciary

This committee has direct oversight over intellectual property (patents), which is foundational to the pharmaceutical industry. Its role in antitrust enforcement also directly impacts mergers, competition, and drug pricing practices.